Gloria Lutzny-Geier

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2025
Functional differences between CLL- and ALL-derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL-10 as potential modulatory targets.

Janin Dingfelder, Michael Aigner, Jana Lindacher

|Aug 14, 2025
3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia.

Jana Lindacher, Anne Hartebrodt, Janin Dingfelder

|Jan 25, 2025
Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients.

Janin Dingfelder, Jule Taubmann, Franziska von Heydebrand

|Aug 25, 2023
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response.

Franziska Gsottberger, Christina Meier, Anna Ammon

|May 17, 2021
Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia.

Sarah Handl, Franziska von Heydebrand, Simon Voelkl

|Feb 04, 2021
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.

Franziska von Heydebrand, Maximilian Fuchs, Meik Kunz

Pageof 2

Frequent Collaborators

2 joint publications

Pascal Lukas

1 joint publications

Andrew Moore

1 joint publications

Katherine Hughes

1 joint publications

Simón Méndez-Ferrer